Cybin Inc. (CYBN) is a publicly traded Healthcare sector company. As of August 3, 2026, CYBN trades at $8.28 with a market cap of $413.12M and a P/E ratio of 0.00. CYBN moved +0.12% today. Year to date, CYBN is -3.50%; over the trailing twelve months it is -6.12%. Its 52-week range spans $4.81 to $10.73. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces CYBN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CYBN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $8.28 |
| Market Cap | $413.12M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.73 |
| 52-Week Low | $4.81 |
| Volume | 716.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover CYBN: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.